• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型霍乱疫苗

New cholera vaccines.

作者信息

Holmgren J, Clemens J, Sack D A, Svennerholm A M

机构信息

Department of Medical Microbiology, University of Göteborg, Sweden.

出版信息

Vaccine. 1989 Apr;7(2):94-6. doi: 10.1016/0264-410x(89)90042-x.

DOI:10.1016/0264-410x(89)90042-x
PMID:2665353
Abstract

Development of improved cholera vaccines has progressed rapidly in recent years. An oral killed vaccine, designed to evoke antibacterial as well as antitoxic intestinal immunity, has proved to be completely safe and to protect against cholera for at least 3 years. This vaccine also confers substantial though more short-lasting immunity against diarrhoea caused by enterotoxigenic Escherichia coli. Significant progress has also been made towards developing a live attenuated cholera vaccine using recombinant DNA techniques. The advent of effective oral cholera vaccines gives hope for improved control of cholera in the Third World.

摘要

近年来,改良霍乱疫苗的研发进展迅速。一种口服灭活疫苗,旨在激发抗菌以及抗毒性肠道免疫,已被证明完全安全,并且能预防霍乱至少3年。这种疫苗还能对产肠毒素大肠杆菌引起的腹泻提供显著但持续时间较短的免疫力。利用重组DNA技术开发减毒活霍乱疫苗也取得了重大进展。有效口服霍乱疫苗的出现为改善第三世界霍乱的控制带来了希望。

相似文献

1
New cholera vaccines.新型霍乱疫苗
Vaccine. 1989 Apr;7(2):94-6. doi: 10.1016/0264-410x(89)90042-x.
2
Development of oral vaccines against cholera and enterotoxinogenic Escherichia coli diarrhea.抗霍乱和产肠毒素大肠杆菌腹泻口服疫苗的研发。
Scand J Infect Dis Suppl. 1990;76:47-53.
3
A review of the current status of enteric vaccines.肠道疫苗现状综述
P N G Med J. 1995 Dec;38(4):325-31.
4
Cholera as a model for research on mucosal immunity and development of oral vaccines.霍乱作为黏膜免疫研究及口服疫苗开发的模型。
Curr Opin Immunol. 1992 Aug;4(4):387-91. doi: 10.1016/s0952-7915(06)80027-0.
5
Oral cholera vaccines: use in clinical practice.口服霍乱疫苗:在临床实践中的应用
Lancet Infect Dis. 2006 Jun;6(6):361-73. doi: 10.1016/S1473-3099(06)70494-7.
6
An oral B subunit: whole cell vaccine against cholera.一种口服B亚单位:全细胞霍乱疫苗。
Vaccine. 1992;10(13):911-4. doi: 10.1016/0264-410x(92)90324-d.
7
Mucosal antitoxic and antibacterial immunity after cholera disease and after immunization with a combined B subunit-whole cell vaccine.霍乱病后及用B亚单位-全细胞联合疫苗免疫后的黏膜抗毒和抗菌免疫。
J Infect Dis. 1984 Jun;149(6):884-93. doi: 10.1093/infdis/149.6.884.
8
Cholera vaccines.霍乱疫苗
Clin Infect Dis. 2000 Aug;31(2):561-5. doi: 10.1086/313951. Epub 2000 Sep 7.
9
Live oral vaccines against cholera: an update.霍乱口服活疫苗:最新进展
Vaccine. 1993;11(2):207-12. doi: 10.1016/0264-410x(93)90019-t.
10
Current status of cholera and rise of novel mucosal vaccine.霍乱的现状与新型黏膜疫苗的兴起
Jpn J Infect Dis. 2000 Oct;53(5):181-8.

引用本文的文献

1
Nontoxigenic Vibrio cholerae Challenge Strains for Evaluating Vaccine Efficacy and Inferring Mechanisms of Protection.无毒力霍乱弧菌挑战株用于评估疫苗效力和推断保护机制。
mBio. 2022 Apr 26;13(2):e0053922. doi: 10.1128/mbio.00539-22. Epub 2022 Apr 7.
2
Behavior of an Aeromonas hydrophila aroA live vaccine in water microcosms.嗜水气单胞菌aroA活疫苗在水微宇宙中的行为。
Appl Environ Microbiol. 2004 May;70(5):2702-8. doi: 10.1128/AEM.70.5.2702-2708.2004.
3
Optimal delivery of vaccines: clinical pharmacokinetic considerations.
疫苗的最佳接种:临床药代动力学考量
Clin Pharmacokinet. 1996 Jan;30(1):1-15. doi: 10.2165/00003088-199630010-00001.
4
Immune response in the lungs following oral immunization with bacterial lysates of respiratory pathogens.用呼吸道病原体细菌裂解物进行口服免疫后肺部的免疫反应。
Clin Diagn Lab Immunol. 1994 Mar;1(2):150-4. doi: 10.1128/cdli.1.2.150-154.1994.
5
Activation of cholera toxin-specific T cells in vitro.霍乱毒素特异性T细胞的体外激活。
Infect Immun. 1990 Nov;58(11):3711-6. doi: 10.1128/iai.58.11.3711-3716.1990.
6
Site-specific mutagenesis of the catalytic subunit of cholera toxin: substituting lysine for arginine 7 causes loss of activity.霍乱毒素催化亚基的位点特异性诱变:将精氨酸7替换为赖氨酸会导致活性丧失。
Infect Immun. 1991 Nov;59(11):4266-70. doi: 10.1128/iai.59.11.4266-4270.1991.
7
Oral delivery of vaccines. Formulation and clinical pharmacokinetic considerations.疫苗的口服给药。制剂与临床药代动力学考量
Clin Pharmacokinet. 1992 Jan;22(1):1-10. doi: 10.2165/00003088-199222010-00001.